Data Analytics Department, Biomérieux, 3 Route de Port Michaud, 38390, La Balme Les Grottes, France.
Clinical Unit, Biomérieux, 3 Route de Port Michaud, 38390, La Balme Les Grottes, France.
Med Microbiol Immunol. 2020 Jun;209(3):217-223. doi: 10.1007/s00430-019-00643-4. Epub 2019 Nov 29.
Industrial and academic needs for innovation and fundamental research are essential and not widely different. Depending on the industrial setting, research and development (R&D) activities may be more focused on the developmental aspects given the need to ultimately sell useful products. However, one of the biggest differences between academic and industrial R&D will usually be the funding model applied and the priority setting between innovative research and product development. Generalizing, companies usually opt for development using customer- and consumer-derived funds whereas university research is driven by open innovation, mostly funded by taxpayer's money. Obviously, both approaches require scientific rigor and quality, dedication and perseverance and obtaining a PhD degree can be achieved in both settings. The formal differences between the two settings need to be realized and students should make an educated choice prior to the start of PhD-level research activities. Intrinsic differences in scientific approaches between the two categories of employers are not often discussed in great detail. We will here document our experience in this field and provide insights into the need for purely fundamental research, industrial R&D and current mixed models at the level of European funding of research. The field of diagnostics in clinical bacteriology and infectious diseases will serve as a source of reference.
工业和学术界都对创新和基础研究有需求,这两者的需求本质上并无太大区别。根据工业环境的不同,研发活动可能更侧重于发展方面,因为最终需要销售有用的产品。然而,学术和产业研发之间最大的区别之一通常是所采用的资金模式以及创新研究和产品开发之间的优先级设置。一般来说,公司通常选择利用客户和消费者资金进行开发,而大学研究则由开放创新驱动,主要由纳税人的钱资助。显然,这两种方法都需要科学严谨性和质量,需要投入和坚持,并且在这两种环境中都可以获得博士学位。需要认识到这两种设置之间的形式差异,学生在开始博士级别的研究活动之前应该做出明智的选择。这两类雇主在科学方法上的内在差异通常没有详细讨论。我们将在这里记录我们在这一领域的经验,并深入了解纯粹基础研究、产业研发以及当前在欧洲研究资助层面的混合模式的必要性。临床细菌学和传染病学领域的诊断学将作为参考来源。